Notes to the Company Financial Statements 1 General information and accounting policies A description of the Company, its activities and definitions are included in note 1 to the consolidated financial statements.
The Company has applied accounting policies identical to the Groups accounting policies listed in note 2 to the consolidated financial statements other than in relation to investments in its subsidiaries which are held at cost less any impairment provision required.
Under Section 10 2 of the Gibraltar Consolidated Accounts Act 1999, the Company is exempt from the requirement to present its own income statement.
2 Investments in subsidiaries The Companys subsidiaries are listed in note 19 to the consolidated financial statements and are held at cost less provision for any impairment.
The Group has adopted IFRIC 11 Group and treasury share transactions.
The effect of adopting this is that the parent Company recognises as a cost of investment the value of its own shares that it makes available for the purpose of granting share options to employees or contractors of its subsidiaries.
This has no impact on the Group financial statements, and no impact on the prior year profit or net assets of the parent Company.
The movement on investment in subsidiaries in both years was in respect of IFRIC 11.
3 Trade and other receivables 31 December 31 December 2008 2007 US$000 US$000 Amounts due from subsidiaries 134,345 82,492 Other receivables and prepayments 338 1,153 134,683 83,645 The carrying value of trade and other receivables approximate to their fair value.
None of the balances included within trade and other receivables are past due or impaired.
Amounts due from subsidiaries are payable on demand.
4 Cash and cash equivalents 31 December 31 December 2008 2007 US$000 US$000 Cash and cash equivalents 38,308 86,904 Restricted cash 257 216 38,565 87,120 Restricted cash primarily relates to deposits held by banks for guarantees.
5 Share capital The disclosures in note 17 to the consolidated financial statements are identical for the Company.
6 Financial assets The disclosures in note 13 to the consolidated financial statements are identical for the Company.
7 Trade and other payables 31 December 31 December 2008 2007 US$000 US$000 Trade payables 189 166 Amounts due to subsidiaries 163,201 152,022 Corporate tax 175 65 Other payables and accrued expenses 3,088 3,468 166,653 155,721 The carrying value of trade and other payables approximate to their fair value.
All balances included within trade and other payables are repayable on demand.
indd 82 08 04 2009 11:18 08 04 2009 11:18 16254 8 4 2009 Proof 7 Notes to the Company Financial Statements 8 Share capital and reserves Share Share  capital premium sale reserve earnings Total US$000 US$000 US$000 US$000 US$000 Balance at 1 January 2007 3,073 16,863 19,936 Net profit for the year 31,157 31,157 Dividend paid 36,205 36,205 Issue of shares 24 24 Share benefit charges 7,800 7,800 Valuation losses of available-for-sale investments 105 105 Balance at 1 January 2008 3,097 105 19,591 22,583 Net profit for the year 15,615 15,615 Dividend paid 25,628 25,628 Issue of shares 18 18 Exercise of market value options 65 65 Share benefit charges 8,391 8,391 Valuation losses of available for sale investments 431 431 Balance at 31 December 2008 3,115 65 536 17,951 20,595 9 Financial risk management The Companys financial risk management objectives and policies are identical to those of the Group as disclosed in note 24 to the consolidated financial statements.
10 Contingent liabilities The disclosures in note 26 to the consolidated financial statements are identical for the Company.
11 Share-based payment The disclosures in note 21 to the consolidated financial statements are identical for the Company.
12 Related party transactions During the year the Company received dividends from its subsidiaries totalling US$25,628,000 2007: US$36,205,000 and paid to its shareholders dividends totalling US$25,628,000 2007: US$36,205,000.
Remuneration paid to Directors of the Company by its subsidiaries in the year totalled US$176,000 2007: US$427,000.
Share benefit charges in respect of options and shares of the Company awarded to employees of subsidiaries totalled US$6,892,000 2007: US$4,623,000.
During the year subsidiaries of the Company participated in funding its costs which totalled US$8,862,000 2007: US$5,690,000.
At 31 December 2008, net amount owed by the Company to its subsidiaries US$28,856,000 2007: US$69,530,000.
